14 research outputs found
Why Reform Fails : The ‘Politics of Policies’ in Costa Rican Telecommunications Liberalization
As the \u27Washington Consensus\u27 reforms are losing momentum in Latin America, the Inter-
American Development Bank (IDB) is calling for shifting the focus from the content of policy
choices to the political process of their implementation. As this paper studies the paradigmatic
case of telecommunications reform in Costa Rica it underscores the importance
of these \u27politics of policies\u27. The analysis finds, however, that the failure of repeated liberalization
initiatives was not only due to policy-makers\u27 errors in steering the project
through \u27the messy world of politics\u27 (IDB); instead, as liberalization remained unpopular,
policy content indeed mattered, and only the interaction of both explains the outcome.
Particular attention is drawn to the political feed-back effects, as the failed reform, precisely
because it had been backed by bi-partisan support, became a catalyst for the disintegration
of the country\u27s long-standing two-party system.In dem Maße, in dem die mit dem „Washington Consensus“ verbundenen Reformen in Lateinamerika
ins Stocken geraten sind, plädiert die Inter-American Development Bank (IDB)
für eine stärkere Berücksichtigung nicht nur der Politikinhalte (policies), sondern auch des
politischen Prozesses von deren Umsetzung (politics). Die vorliegende Untersuchung zum
paradigmatischen Fall der Reform des Telekommunikationssektors in Costa Rica unterstreicht
die Bedeutung dieser „politics of policies“. Sie zeigt allerdings auch, dass Ursache
für das Scheiten wiederholter Liberalisierungsinitiativen nicht nur Fehler der Politiker sind,
das Vorhaben durch „die unordentliche Welt der politics“ (IDB) zu steuern. Die breite gesellschaftliche
Opposition gegen den Liberalisierungskurs bleibt. Nur die Interaktion von beiden,
politics und policies, erklärt Verlauf und Ergebnis der Reform. Besonderes Augenmerk
widmet die Studie den politischen Rückwirkungen der gescheiterten Reform: Sie wurde,
just weil sie von beiden etablierten Parteien unterstützt wurde, zum Katalysator für den Zerfall
des seit Jahrzehnten etablierten Zweiparteiensystems des Landes
Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study
Background: The impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on postoperative recovery needs to be understood to inform clinical decision making during and after the COVID-19 pandemic. This study reports 30-day mortality and pulmonary complication rates in patients with perioperative SARS-CoV-2 infection. Methods: This international, multicentre, cohort study at 235 hospitals in 24 countries included all patients undergoing surgery who had SARS-CoV-2 infection confirmed within 7 days before or 30 days after surgery. The primary outcome measure was 30-day postoperative mortality and was assessed in all enrolled patients. The main secondary outcome measure was pulmonary complications, defined as pneumonia, acute respiratory distress syndrome, or unexpected postoperative ventilation. Findings: This analysis includes 1128 patients who had surgery between Jan 1 and March 31, 2020, of whom 835 (74·0%) had emergency surgery and 280 (24·8%) had elective surgery. SARS-CoV-2 infection was confirmed preoperatively in 294 (26·1%) patients. 30-day mortality was 23·8% (268 of 1128). Pulmonary complications occurred in 577 (51·2%) of 1128 patients; 30-day mortality in these patients was 38·0% (219 of 577), accounting for 81·7% (219 of 268) of all deaths. In adjusted analyses, 30-day mortality was associated with male sex (odds ratio 1·75 [95% CI 1·28–2·40], p\textless0·0001), age 70 years or older versus younger than 70 years (2·30 [1·65–3·22], p\textless0·0001), American Society of Anesthesiologists grades 3–5 versus grades 1–2 (2·35 [1·57–3·53], p\textless0·0001), malignant versus benign or obstetric diagnosis (1·55 [1·01–2·39], p=0·046), emergency versus elective surgery (1·67 [1·06–2·63], p=0·026), and major versus minor surgery (1·52 [1·01–2·31], p=0·047). Interpretation: Postoperative pulmonary complications occur in half of patients with perioperative SARS-CoV-2 infection and are associated with high mortality. Thresholds for surgery during the COVID-19 pandemic should be higher than during normal practice, particularly in men aged 70 years and older. Consideration should be given for postponing non-urgent procedures and promoting non-operative treatment to delay or avoid the need for surgery. Funding: National Institute for Health Research (NIHR), Association of Coloproctology of Great Britain and Ireland, Bowel and Cancer Research, Bowel Disease Research Foundation, Association of Upper Gastrointestinal Surgeons, British Association of Surgical Oncology, British Gynaecological Cancer Society, European Society of Coloproctology, NIHR Academy, Sarcoma UK, Vascular Society for Great Britain and Ireland, and Yorkshire Cancer Research
Los procesos de corrupción y las prespectivas de la democracia en Costa Rica
Habitualmente Costa Rica era considerada la democracia latinoamericana menos susceptible de experimentar corrupción. Los recientes escándalos, que involucran a dos ex-presidentes y varios representantes de instituciones locales y corporaciones internacionales, dan cuenta de un notorio cambio en ese estado de cosas. Este análisis muestra cómo la consolidación de un sistema bipartidista en conjunción con estrategias de reducción del Estado han puesto en tela de juicio la solvencia de la democracia costarricense. Aunque el proceso ha sembrado el escepticismo en un electorado tradicionalmente entusiasta, los ciudadanos cuentan con instituciones de fiscalización y justicia responsables y eficaces
Disseny de materials per a l'aprenentatge d'habilitats jurídiques fonamentals
Se describe el proceso de generación de materiales cuyo contenido son las denominadas “habilidades jurídicas fundamentales”. Se han elaborado con la herramienta de materiales en línea de la plataforma docente de la Universitat de València, Aula Virtual (http://aulavirtual.uv.es) y en la web: www.uv.es/legalskills. Se han utilizado diversas aplicaciones informáticas: eXelearning para empaquetar en formato SCORM, programas de simulación, edición de video… Los videos se han depositado en un servidor streaming en formato flash y mp4. Los materiales pretenden favorecer el aprendizaje autónomo de los estudiantes de Primer Ciclo de la Licenciatura en Derecho y paliar las deficiencias en la adquisición coherente de estas habilidades
Resultados da cirurgia de catarata em pacientes diabéticos : resultados do Pan-American Collaborative Retina Study Group
Purpose: This study was designed to evaluate the visual and anatomical outcomes after cataract surgery in diabetic patients with different intraoperative therapeutic strategies. Methods: The research design comprised of a multicentric, retrospective, interventional study conducted at 6 centers in Argentina, Brazil, Costa Rica, Puerto Rico, Spain, and Venezuela. We included 138 diabetic patients with at least 6-month follow-up following phacoemulsification and intraocular lens implantation. Best-corrected visual acuity (BCVA) and central subfield thickness were collected at baseline and at 1-, 2-, 3-, and 6-month follow-up. Of these, 42 cases were not treated with any intraoperative coadjuvant medication (Group 1), 59 patients received intraoperative bevacizumab (Group 2) and 37 patients received intraoperative triamcinolone (4 mg/0.1 ml) (Group 3). Results: The mean logMAR [± standard deviation (SD)] BCVA improved from 0.82 (± 0.43) at baseline, to 0.14 (± 0.23) at 6-month follow-up (p<0.001) in Group 1; from 0.80 (± 0.48) to 0.54 (± 0.45) (p<0.001) in Group 2; and from 1.0 (± 0.40) to 0.46 (± 0.34) (p<0.001) in Group 3. The mean central subfield thickness increased from 263.57 μm (± 35.7) at baseline to 274.57 μm (± 48.7) at 6-month follow-up (p=0.088) in Group 1; from 316.02 μm (± 100.4) to 339.56 μm (± 145.3) (p=0.184) in Group 2; and from 259.18 μm (± 97.9) to 282.21 μm (± 87.24) (p=0.044) in Group 3. Conclusions: Diabetic patients may significantly benefit from cataract surgery. This study provides evidence to support the use of intravitreal triamcinolone or bevacizumab at the time of cataract surgery in cases with pre-existent diabetic macular edema or moderate-severe non-proliferative diabetic retinopathy
Resultados da cirurgia de catarata em pacientes diabéticos : resultados do Pan-American Collaborative Retina Study Group
Purpose: This study was designed to evaluate the visual and anatomical outcomes after cataract surgery in diabetic patients with different intraoperative therapeutic strategies. Methods: The research design comprised of a multicentric, retrospective, interventional study conducted at 6 centers in Argentina, Brazil, Costa Rica, Puerto Rico, Spain, and Venezuela. We included 138 diabetic patients with at least 6-month follow-up following phacoemulsification and intraocular lens implantation. Best-corrected visual acuity (BCVA) and central subfield thickness were collected at baseline and at 1-, 2-, 3-, and 6-month follow-up. Of these, 42 cases were not treated with any intraoperative coadjuvant medication (Group 1), 59 patients received intraoperative bevacizumab (Group 2) and 37 patients received intraoperative triamcinolone (4 mg/0.1 ml) (Group 3). Results: The mean logMAR [± standard deviation (SD)] BCVA improved from 0.82 (± 0.43) at baseline, to 0.14 (± 0.23) at 6-month follow-up (p<0.001) in Group 1; from 0.80 (± 0.48) to 0.54 (± 0.45) (p<0.001) in Group 2; and from 1.0 (± 0.40) to 0.46 (± 0.34) (p<0.001) in Group 3. The mean central subfield thickness increased from 263.57 μm (± 35.7) at baseline to 274.57 μm (± 48.7) at 6-month follow-up (p=0.088) in Group 1; from 316.02 μm (± 100.4) to 339.56 μm (± 145.3) (p=0.184) in Group 2; and from 259.18 μm (± 97.9) to 282.21 μm (± 87.24) (p=0.044) in Group 3. Conclusions: Diabetic patients may significantly benefit from cataract surgery. This study provides evidence to support the use of intravitreal triamcinolone or bevacizumab at the time of cataract surgery in cases with pre-existent diabetic macular edema or moderate-severe non-proliferative diabetic retinopathy